ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.

Slides:



Advertisements
Similar presentations
Idiopathic Thrombocytopenic Purpura
Advertisements

Haematology Jennie Wimperis Consultant Haematologist Norfolk and Norwich University Hospital.
Heather D. Mannuel, MD, MBA March 12, 2008
Complete blood count in primary care. Key points/purpose  Provide an overview of the use of the complete blood count in primary care  Provide advice.
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Normocytic Anemia Dr. Fatin Al-Sayes, MD, MSc, MRCPath Consultant Hematology / Assistant Professor King Abdulaziz University Hospital.
Michael F. McNamara, DO Sanford Maternal Fetal Medicine.
بسم الله الرحمن الرحيم.
Acute Lymphoblastic Leukemia Maggie Davis Hovda 5/26/2009.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Platelet Disorders. Platelets *Disc shape cells 2-4 mm in diameter. *They have blue grey cytoplasm with red lysosomal granules, but devoid of nuclei.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
Polycythemia Group C: Melanie, Michele, Sarah.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Immune System InnativeAdaptive A) Skin and Mucosal membranes B) Secreted soluble proteins - Lysozyme -C-creative protein - Interferons - Complement system.
 Thrombocytopenia in the absence of other blood cell abnormalities (normal RBC & WBC, normal peripheral smear)
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Salwa Hindawi. MSc, MRCPath, CTM RCPE Director of Blood Transfusion Services King Abdulaziz University Hospital Jeddah, Saudi Arabia.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Chronic Lymphocytic Leukemia (CLL) DEFINITION CLL is a neoplastic disease characterized by proliferation and accumulation (blood, marrow and lymphoid.
November 23, Idiopathic Throbocytopenic Purpura.
ORGAN-SPECIFIC AUTOIMMUNE DISEASES Prof Peter Gergely ORGAN-SPECIFIC AUTOIMMUNE DISEASES Prof Peter Gergely Classification of organ-specific autoimmune.
Splenectomy in Hematologic Disorders
HIV and haematology Mike Webb Division of Clinical Haematology 5 March 2011.
Quantitative and qualitative platelet disorders
The Immune System u Widely dispersed system u Review of structure and function F located in marrow cavities of bones F yellow vs. red marrow F hematopoiesis.
Malignancy  NHL 7.7% - mostly extranodal, all B cell type  Others - –Waldenstrom’s macroglobulinemia –Hodgkin’s disease –Adenocarcinoma - stomach, ovary,
INFECTIOUS MONONUCLEOSIS (epstein-barr virus) Professor: Ma lian.
Hemophagocytic Syndromes Maggie Davis Hovda Morning Report 10/30/2009.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
ITP: The Past Decade Ming Hou Qilu Hospital, Shandong University.
Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated.
HIV and haematology Mike Webb Division of Clinical Haematology 8 Feb 2010.
Clinical Features.
Warm Autoimmune Hemolytic Anemia Lisa Rose-Jones, MD Monday, Aug 24th.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Chronic lymphocytic leukemia What is C.L.L. ? a chronic disease one particular type of lymphocyte (B-cells) accumulates. not rapidly growing and proliferating.
IMMUNE THROMBOCYTOPENIC PURPURA (ITP) Dr. Mohamed Haseen Basha Dr. Mohamed Haseen Basha Assistant professor ( Pediatrics) Faculty of Medicine Al Maarefa.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Hematology Block: Overview and Advice Tim Boswell, M4 Presentation created on 3/21/16.
This program is supported by an educational donation from Howard Liebman, MD Chief, Hematology Section Professor of Medicine and Pathology Keck School.
Thrombocytopenia Chapter 31 Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
What you need to know about CBC and coagulation profile Dr. Khalid Alsaleh MRCP,FACP,FRCPC,MSc.
Blood : R2 임규성.  Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by low platelet counts and may be responsible.
Coagulation tests CBC- complete blood count
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura Journal.
The pathogenesis of immune thrombocytopaenic purpura Nichola Cooper and James Bussel Department of Pediatrics, Weill Medical College of Cornell University,
Acquired Hemolytic Anemias
THROMBOCYTOPENIA Reduction in platelet count below 150 x 109
State University of Medicine and Pharmacy "Nicolae Testemitanu“ Departmen of pediatric Subject : Aplastic anemia Amaria Ibrahem Group m1249 presented to.
IMMUNE PLATELET DESTRUCTION
Disseminated Intravascular Coagulation
NEONATAL IMMUNE THROMBOCYTOPENIA
IDOPATHIC THROMBOCYTOPENIA PURPURA
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
What you need to know about CBC and coagulation profile
Estimated fraction of the various forms of secondary ITP based on clinical experience of the authors. The incidence of Helicobacter pylori (HP) ranges.
CHRONIC LYMPHOCYTIC LEUKAEMIA CLL
What you need to know about CBC and coagulation profile
Autoimmune disease in pregnancy
Common Variable Immunodeficiency
Approach to Thrombocytopenia
DIATHESIS HAEMORRHAGIS.
Chronic Leukemia Kristine Krafts, M.D..
The Fascinating World of Haemostasis and Thrombosis
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
Immune thrombocytopenic purpura (ITP)
An unusual case of Menorrhagia in a young girl
Presentation transcript:

ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010

Definition Autoimmune disorder resulting in destruction of platelets Classified as primary vs secondary, and acute (<6 mos) vs chronic Among adults, the most common age group is yrs More common in females (2-3:1)

Pathophysiology 1) Macrophages digest membrane GPIIb/IIIa or GPIb/IX phagocytosed platelets 2) Macrophages then present the antigens to autoreactive CD4+ T cells and thereby activate them 3) T cells exert helper activity on autoreactive Ab producing B cells 4) B cells produce Ab to platelets marking them for phagocytosis & destruction by macrophages

Pathophysiology Often there is compensatory increase in platelet production, however this can be impaired by – 1) intramedullary destruction of Ab coated platelets by macrophages OR – 2) inhibition of megakaryocytopoiesis

Clinical Features Mucocutaneous bleeding Purpura (petechiae, ecchymoses) Normal lymph node exam, no splenomegaly w/primary ITP

Diagnosis One of exclusion Isolated thrombocytopenia is present Associated conditions, drugs, or other thrombocytopenia inducing agents are NOT present Lab Data: -CBC w/diff looking for isolated thrombocytopenia - Peripheral smear

Secondary ITP Drugs (heparin, quinidine, sulfazalazine) Lymphoproliferative disease (CLL, lymphoma) SLE APLA syndrome Hepatitis C infection HIV CVID EBV IgA deficiency Sarcoidosis

Treatment Usually initiate with platelets <20 or <50 w/ bleeding Corticosteroids are first line – Decadron burst 40 mg daily x 4 days vs – Prednisone 1-2 mg/kg over 2-6 wks with taper IVIG Rituximab Anti –D Azathioprine Cyclosporine Cyclophosphamide Vinca alkaloids Danazol Splenectomy: considered when fail medical therapy w/ plt counts <30 for 4-6 weeks

Prognosis Fatal bleeding occurs from ICH with risk greatest in elderly Mortality rates 0.3-5% However, some believe the higher mortality rates are not reflective of modern practices and treatments and therefore estimate lifelong incidence of major bleeding and death from bleeding to be <1%